Avella Recalls Norepinephrine Bags Due to Potential Leakage and Sterility Concerns
Avella of Deer Valley is recalling 2,280 bags of Norepinephrine Bitartrate in 5% Dextrose due to potential bag leakage and lack of sterility assurance.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves a lack of sterility assurance in an injectable medication, which poses a significant risk of serious injury or death if contaminated product is administered.
Plain-English summary
Avella of Deer Valley, Inc. is recalling 2,280 bags of NORepiNEPHrine4mg (Norepinephrine Bitartrate (USP) 4 mg added to 5% Dextrose Inj. (USP) 250 mL). The product is a single-dose bag with a concentration of 16 mcg/mL and a volume of 254 mL. The recall is being conducted because of a lack of assurance of sterility, specifically due to potential leakage of the bags.
The affected product was distributed nationwide in the USA. The specific lots involved are: Lot # 4/30/18 2471 80725P with a beyond-use date of 6/29/2018; Lot # 5/1/18 1240 80725P with a beyond-use date of 6/30/2018; and Lot # 5/8/18 1111 80725P with a beyond-use date of 7/7/2018. The NDC number for the product is 42852-807-25.
Healthcare providers and facilities should stop using the affected lots and contact the recalling firm for instructions on return or disposal. Patients who have received this medication should contact their healthcare provider if they have any concerns or experience adverse effects.
The recalled product
- Product
- NORepiNEPHrine4mg (Norepinephrine Bitartrate (USP) 4 mg added to 5% Dextrose Inj. (USP) 250 mL (Concentration 16 mcg/mL) Volume: 254 mL Single dose bag. Avella of Houston, 9265 Kirby Dr. Houston, TX 77054. NDC 42852-807-25
- Manufacturer
- Avella of Deer Valley, Inc. Store 38
- Category
- Drug — Injectable Medication
- Affected units
- 2,280
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- Lot #: 4/30/18 2471 80725P
- BUD 6/29/2018
- 5/1/18 1240 80725P
- BUD 6/30/2018
- 5/8/18 1111 80725P BUD 7/7/2018.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 38 recalled by Avella of Deer Valley, Inc. Store 38 under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 38 products in this recall →Related recalls
Same manufacturer · Avella of Deer Valley, Inc. Store 38
See all →- SevereAvella Recalls Povidone Iodine Ophthalmic Solution Due to Sterility Concerns
FDA (Drugs) · 2019-10-30
- SevereAvella Recalls Bevacizumab Prefilled Syringes Due to Sterility Concerns
FDA (Drugs) · 2019-06-05
- ModerateAvella recalls magnesium sulfate bags with incorrect barcode expiration dates
FDA (Drugs) · 2019-02-20
- ModerateAvella Recalls Labetalol Syringes Due to Incorrect Barcode Expiration Dates
FDA (Drugs) · 2019-02-20
- ModerateAvella recalls magnesium sulfate bags with incorrect barcode expiration dates
FDA (Drugs) · 2019-02-20
Same hazard · sterility
See all →- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- SeverePrestige Recalls Clear Eyes Maximum Itchy Eye Relief Due to Sterility Concerns
FDA (Drugs) · 2026-08-19
- SevereFDA Recalls ROHTO OPTIC GLOW Eye Drops Over Sterility Concerns
FDA (Drugs) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SevereROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29